PL1905773T3 - Związki i sposoby hamowania progresji mitotycznej poprzez hamowanie kinazy aurora - Google Patents
Związki i sposoby hamowania progresji mitotycznej poprzez hamowanie kinazy auroraInfo
- Publication number
- PL1905773T3 PL1905773T3 PL07024446T PL07024446T PL1905773T3 PL 1905773 T3 PL1905773 T3 PL 1905773T3 PL 07024446 T PL07024446 T PL 07024446T PL 07024446 T PL07024446 T PL 07024446T PL 1905773 T3 PL1905773 T3 PL 1905773T3
- Authority
- PL
- Poland
- Prior art keywords
- inhibition
- compounds
- methods
- aurora kinase
- mitotic progression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57165304P | 2004-05-14 | 2004-05-14 | |
| US61722104P | 2004-10-08 | 2004-10-08 | |
| EP07024446A EP1905773B1 (en) | 2004-05-14 | 2005-05-12 | Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase |
| EP05779921A EP1771450B9 (en) | 2004-05-14 | 2005-05-12 | Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1905773T3 true PL1905773T3 (pl) | 2012-12-31 |
Family
ID=39126531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07024446T PL1905773T3 (pl) | 2004-05-14 | 2005-05-12 | Związki i sposoby hamowania progresji mitotycznej poprzez hamowanie kinazy aurora |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1905773B1 (pl) |
| DK (1) | DK1905773T3 (pl) |
| PL (1) | PL1905773T3 (pl) |
| SI (1) | SI1771450T1 (pl) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4318854A (en) | 1979-02-07 | 1982-03-09 | Hoffmann-La Roche Inc. | Intermediates in the production of 2-benzazepines |
| US4547581A (en) | 1979-02-07 | 1985-10-15 | Hoffmann-La Roche Inc. | Pyrimido-2-benzazepines and intermediates in their preparation |
| EP0946523A1 (en) * | 1996-12-23 | 1999-10-06 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
| GB9914258D0 (en) | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
| NZ526471A (en) * | 2000-12-21 | 2005-08-26 | Vertex Pharma | Pyrazole compounds useful as protein kinase inhibitors |
-
2005
- 2005-05-12 EP EP07024446A patent/EP1905773B1/en active Active
- 2005-05-12 PL PL07024446T patent/PL1905773T3/pl unknown
- 2005-05-12 DK DK07024446.2T patent/DK1905773T3/da active
- 2005-05-12 SI SI200530184T patent/SI1771450T1/sl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK1905773T3 (da) | 2012-10-15 |
| EP1905773A3 (en) | 2008-04-09 |
| SI1771450T1 (sl) | 2008-06-30 |
| EP1905773A2 (en) | 2008-04-02 |
| EP1905773B1 (en) | 2012-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1205102A1 (en) | Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase | |
| ME00716B (me) | Jedinjenja i postupci za inhibiciju mitotičke progresije inhibiranjem aurora kinaze | |
| EP1957078A4 (en) | PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING CANCER BY INHIBITING AURORA KINASE | |
| HK1096972A1 (en) | Inhibition of syk kinase expression | |
| GB2432165B (en) | Method of inhibiting hydrate formation | |
| IL189933A0 (en) | Rna antagonist compounds for the inhibition of apo-b100 expression | |
| EP2121637A4 (en) | ANTHRANILAMIDE INHIBITORS OF AURORA KINASE | |
| IL190727A0 (en) | Method of inhibiting flt3 kinase | |
| HK1134672A1 (en) | Compounds for inhibiting mitotic progression | |
| ZA200704106B (en) | Inhibitors of c-fms kinase | |
| EP1954290A4 (en) | AS KINASE-HEMMER USES TRICYCLIC COMPOUNDS | |
| IL172375A0 (en) | Chinazoline derivatives as aurora kinase inhibitors | |
| EP1778693A4 (en) | AS KINASEINHIBITORS USEFUL COMPOUNDS OF TRICYCLIC HETEROARYL | |
| HK1144392A1 (en) | Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase | |
| GB0608823D0 (en) | Inhibitors of P13 kinase | |
| ZA200809874B (en) | Method of inhibiting c kit kinase | |
| IL182735A0 (en) | Inhibitors of c-fms kinase | |
| EP1906967A4 (en) | ABL Kinase Inhibition | |
| SI1905773T1 (sl) | Spojine in postopki za inhibiranje mitotične progresije z inhibiranjem aurora kinaze | |
| EP1771203A4 (en) | INHIBITION OF NF-KB | |
| EP1605893A4 (en) | TRANS-MEMBRANE ANTIBODY-INDUCED APOPTOSIS INHIBITION | |
| SI1771450T1 (sl) | Spojine in postopki za inhibiranje mitotične progresije z inhibicijo kinaze Aurora | |
| EP1776140A4 (en) | METHOD FOR INHIBITING VIRAL REPLICATION | |
| GB0410299D0 (en) | Inhibition of biofilm formation | |
| GB0621606D0 (en) | Inhibitors of p13 kinase |